E_DEPRECATED Error in file »functions_general.php« at line 326: Function utf8_encode() is deprecated
E_DEPRECATED Error in file »functions_general.php« at line 333: trim(): Passing null to parameter #1 ($string) of type string is deprecated
Immunocore is one of the world’s leading biotechnology companies, with a highlyinnovative immuno-oncology platform technology called ImmTACs. ImmTACs are anovel class of biologic drugs based on the Company’s proprietary T cell receptor (TCR)technology which have the potential to treat diseases with high unmet medical needincluding cancer, viral infections and autoimmune diseases. Immunocore, based on 3decades of world-leading scientific innovation in the discovery of HLA targets and T cellreceptor technology, has a pipeline of wholly-owned and partnered ImmTACprogrammes with robust clinical data, validated by collaborations with world-leadingpharmaceutical companies. Immunocore aims to leverage the utility of its platformacross a wide range of indications to become a Premier Biotech company and worldleaderin its field.Immunocore’s world-leading science and strong IP position has attracted majorpharmaceutical companies including Genentech, GlaxoSmithKline, MedImmune, thebiologics division of AstraZeneca, via discovery collaborations, as well as a co-discoveryand co-development partnership with Lilly. The Company has also entered intocombination trials with its lead programme, IMCgp100 in melanoma, with Medimmuneand Lilly. Founded in 2008 originally out of Oxford University and headquarteredoutside Oxford, Immunocore now has more than 155 staff. Immunocore is well fundedand owned by a group of international private, institutional and strategic investors.
Keywords: